k.haddad
TL2 · Osijek
Contributes reviews on supplier material. Based in Osijek.
Joined 15 March 2025 · last posted 9d
85 posts, newest first. Showing up to 150.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #60 · Practice › Side effects · 19 Jul 2026 · 18 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Tracking a shortage from primary sources rather than rumour Replied, post #105 · Access › Shortages · 16 Jul 2026 · 0 likes Where the tracking a shortage reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Pooling trials with different estimands Replied, post #89 · Evidence › Meta-analyses · 11 Jul 2026 · 0 likes Overlapping populations across included trials inflate the apparent sample size. It happens more than people expect where the same programme reports multiple papers.…
-
What a certificate commits its issuer to — one year on Replied, post #105 · Analytics › COA interpretation · 8 Jul 2026 · 21 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Shakes versus food: a pragmatic assessment Replied, post #21 · Nutrition & Training › Protein & intake · 3 Jul 2026 · 0 likes Posting my shakes versus food numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Follow-up: Reading an interaction checker output critically Replied, post #24 · Practice › Interactions · 29 Jun 2026 · 1 like Confirming post #23 from a second method, which matters more than confirming it from a second person. Anticoagulants: no direct interaction with the compounds in this…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #17 · Clinical › Comorbidities · 27 Jun 2026 · 10 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them. The mechanism is plausible, which is…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #57 · Analytics › Impurities & related substances · 25 Jun 2026 · 5 likes Where I part company with post #55, and it is a narrow parting. What I would tell a new member reading about Endotoxin for the first time: the confident posts are not…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #36 · Sourcing › Independent verification · 23 Jun 2026 · 8 likes Post #33 answers the question as asked. The question underneath it is different. Practical note on Interpreting a result: write down what you expect before you look.…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #91 · Access › Insurance & coverage · 13 Jun 2026 · 3 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #19 · Compounds › Secretagogues & GH axis · 7 Jun 2026 · 2 likes Answering the question post #15 raises rather than the one it answers. GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms.…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #126 · Practice › Storage & stability · 1 Jun 2026 · 4 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
About the Comorbidities category Replied, post #3 · Clinical › Comorbidities · 29 May 2026 · 11 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Prescription portability between countries Replied, post #41 · Access › International · 23 May 2026 · 18 likes Genuine question rather than a rhetorical one: has anyone here actually observed prescription portability between countries, as opposed to read about it? The thread is…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #12 · Compounds › Semaglutide · 29 Apr 2026 · 1 like I keep a log for semaglutide and gastric emptying specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost…
-
CJC-1295 with and without DAC: what the modification does Replied, post #42 · Compounds › Secretagogues & GH axis · 26 Apr 2026 · 2 likes Post #40 and I disagree about the size of the effect, not about the direction. Posting my CJC-1295 numbers with the method attached so they can be discounted properly.…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #44 · Evidence › Trials · 14 Apr 2026 · 4 likes The documentation on Subgroup analyses is better than this thread and I say that as someone who has posted in the thread.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #13 · Devices › Syringes & needles · 6 Apr 2026 · 29 likes Post #11 and I disagree about the size of the effect, not about the direction. Sharps containers are a legal requirement for disposal in several jurisdictions and a…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #17 · Clinical › Bloodwork · 1 Apr 2026 · 4 likes On post #15 — agreed on the reasoning, with one qualification. I would keep Liver enzymes drifting and the decision it usually gets used for separate in this thread.…
-
Managing an unplanned gap in supply Replied, post #77 · Access › Shortages · 29 Mar 2026 · 7 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Second pass at: Identical chromatograms across two different lots Replied, post #79 · Sourcing › Red flags · 20 Mar 2026 · 5 likes I read post #75 twice before replying, because I had assumed the opposite. Reporting something here requires the batch, the date, the method and the document, which is…
-
Measurement error in home scales, with a worked standard deviation Replied, post #27 · Research Methods › Statistics · 19 Mar 2026 · 1 like Worth separating two things that post #25 runs together. On measurement error in home scales, I would rather understate and be corrected upward than overstate and be…
-
Choosing which test to pay for, given a fixed budget Replied, post #22 · Sourcing › Independent verification · 12 Mar 2026 · 0 likes Post #18 put the caveat in the right place and I want to underline it. The record shows what was measured. Everything beyond that is inference and this site tries to…
-
Measurement error in a self-reported exposure Replied, post #15 · Evidence › Study critique · 22 Feb 2026 · 1 like Second this, and I would have said it less carefully.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #103 · Compounds › Oral incretins · 21 Feb 2026 · 0 likes Building on post #102 rather than restating it. On variability: the between-person spread in exposure for oral semaglutide is wide enough that two people on the same…
-
A history of disordered eating: proceeding carefully Replied, post #73 · Wellbeing › Mental health · 25 Jan 2026 · 19 likes Picking up post #71: that is the part I would want checked first. I think the history of disordered eating question is answerable and has not been answered, which is a…
-
The headache that turns out to be dehydration Replied, post #148 · Nutrition & Training › Hydration & electrolytes · 21 Jan 2026 · 28 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #12 · Analytics › Mass spectrometry · 19 Jan 2026 · 32 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #26 · Regional › UK & Ireland · 31 Dec 2025 · 10 likes Building on post #24 rather than restating it. Where guidance distinguishes between indications, quoting the indication is essential. The same compound has different…
-
The decimal-point error, and the habit that catches it Replied, post #83 · Practice › Reconstitution · 17 Dec 2025 · 27 likes Whatever the answer on decimal-point error turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
Prescription requirements and telehealth models Replied, post #57 · Sourcing › Regulatory · 9 Dec 2025 · 21 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. I am confident about the…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #39 · Analytics › Impurities & related substances · 22 Nov 2025 · 0 likes Two claims get bundled together under Aggregates and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #25 · Practice › Storage & stability · 20 Nov 2025 · 15 likes Building on post #24 rather than restating it. A beyond-use date on a home preparation is an inference rather than a measurement. It can be a reasonable inference and…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #5 · Compounds › Retatrutide · 14 Nov 2025 · 17 likes The phase 3 programme is ongoing and its results will change what can be said here. Until then, this subcategory's convention is to state the phase alongside any result…
-
Micro-titration: a disputed topic, argued properly Replied, post #2 · marked as the solution · Practice › Dosing & titration · 8 Nov 2025 · 7 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. What I would want before treating micro-titration as…
-
High-resolution MS on aggregates and what it can see Replied, post #112 · Analytics › Mass spectrometry · 5 Nov 2025 · 0 likes Resolution: "high resolution" commonly means
-
Journal club: the retatrutide phase 2 obesity paper Replied, post #9 · Evidence › Journal club · 4 Nov 2025 · 4 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #88 · Practice › Storage & stability · 9 Oct 2025 · 0 likes The practical version of power cut for eleven hours is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
Payment method and the leverage it gives you, ranked Replied, post #77 · Sourcing › Payments · 25 Sep 2025 · 9 likes Sensible. I would want the same detail before I acted on it either.
-
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #15 · Evidence › Journal club · 23 Sep 2025 · 21 likes Coming back to post #11, because the follow-up matters more than the original answer. Reading order that works for these sessions: registry entry, methods, baseline…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #20 · Clinical › Special populations · 10 Sep 2025 · 25 likes On Older adults, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #50 · Start Here › How to Ask · 7 Sep 2025 · 5 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
Adolescents: a distinct evidence base — one year on Replied, post #12 · Clinical › Special populations · 28 Aug 2025 · 0 likes I would rather this thread reach "we do not know" about Adolescents than reach a confident answer that nobody can support when asked.
-
A preprint whose numbers changed substantially at publication Replied, post #13 · Evidence › Preprints · 8 Aug 2025 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #35 · Documentation › Doc review · 3 Aug 2025 · 1 like Promotion criteria: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #24 · Compounds › Repair & healing peptides · 29 Jul 2025 · 0 likes Post #23 is the version of this I will quote in future. One addition. On BPC-157, the part that usually goes wrong is that the question is asked as though it has one…
-
What a documentation review can and cannot tell you Replied, post #51 · Sourcing › Independent verification · 28 Jul 2025 · 14 likes What would change my mind on documentation review is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #10 · Sourcing › Red flags · 26 Jul 2025 · 6 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at scale.
-
Coming back to: When "no data" is the complete and final answer Replied, post #52 · Compounds › Other compounds · 20 Jul 2025 · 13 likes On post #48 — agreed on the reasoning, with one qualification. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #42 · Analytics › Method validation · 18 Jul 2025 · 0 likes I have three months of notes on Forced degradation studies and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #14 · Compounds › Retatrutide · 17 Jul 2025 · 19 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
A calculator that gives a right answer to the wrong question — does this still hold? Started this topic · Data & Tools › Calculators · 13 Jul 2025 · 0 likes A calculator that gives a right answer to the wrong question — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is…
-
Trial registration and comparing the protocol with the paper Replied, post #18 · Evidence › Trials · 30 Jun 2025 · 0 likes Coming back to post #14, because the follow-up matters more than the original answer. An open-label trial is not worthless and its subjective endpoints deserve more…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #104 · Wellbeing › Mental health · 18 Jun 2025 · 30 likes On anxiety I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
-
Foaming during reconstitution and whether it matters Replied, post #16 · Practice › Reconstitution · 16 Jun 2025 · 2 likes Post #13 is right about the mechanism and I think understates the practical bit. On foaming during reconstitution I would separate what is worth knowing from what is…
-
Coming back to: Official shortage notices and what they authorise Replied, post #25 · Access › Shortages · 9 Jun 2025 · 0 likes Worth separating two things that post #23 runs together. Shortages end and the notices are updated. Checking the current notice takes a minute and is more reliable than…
-
Half-life, steady state, and accumulation worked through Replied, post #29 · Pharmacology › Pharmacokinetics · 27 May 2025 · 2 likes Half-life is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one…
-
Asking about a compound your prescriber has not heard of Replied, post #45 · Clinical › Prescriber conversations · 21 May 2025 · 13 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #111 · Practice › Reconstitution · 20 May 2025 · 7 likes Post #110 is the version of this I will quote in future. One addition. The failure mode on 5 mg vial is boring rather than dramatic. It is almost always the step…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #3 · Data & Tools › Calculators · 12 May 2025 · 1 like Where I part company with the opening post, and it is a narrow parting. Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #53 · Compounds › Tirzepatide · 12 May 2025 · 13 likes On GIP component of tirzepatide I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them…
-
A claim built entirely on a subgroup analysis Replied, post #2 · Evidence › Study critique · 22 Apr 2025 · 5 likes The documentation on claim built is better than this thread and I say that as someone who has posted in the thread.
-
Adjudicated events and why the definition matters — the long version Replied, post #82 · Evidence › Trials · 5 Apr 2025 · 18 likes Adding the measurement that post #80 says would settle it. The figure that circulates in coverage is almost always whichever estimand gives the larger effect. That is…
-
[2026 update] US compounding rules and how they changed Replied, post #5 · marked as the solution · Regional › North America · 24 Mar 2025 · 7 likes Anyone reporting an outcome should give the stated reason rather than the verdict. The reason is the part somebody else can use. I looked this up rather than remembered…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #34 · Analytics › COA interpretation · 28 Feb 2025 · 8 likes What I can speak to on Counter-ion form is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Telehealth prescribing models in the US Replied, post #62 · Regional › North America · 23 Feb 2025 · 20 likes Building on post #61 rather than restating it. Telehealth prescribing models has been discussed here with more heat than it deserves, mostly because two definitions…
-
Distinguishing a deletion sequence by mass alone Replied, post #92 · Analytics › Mass spectrometry · 15 Feb 2025 · 17 likes I read post #88 twice before replying, because I had assumed the opposite. Purity and identity are different questions: LC-MS establishes that the species at a…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #103 · Evidence › Meta-analyses · 12 Feb 2025 · 0 likes Post #99 put the caveat in the right place and I want to underline it. Quality assessment of included trials should change the analysis rather than sit beside it. A…
-
Recovery when intake is low: what to cut first Replied, post #40 · Nutrition & Training › Resistance training · 12 Jan 2025 · 0 likes Answering the question post #38 raises rather than the one it answers. Machine-based work is often better tolerated when energy is low and is not inferior for this…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #39 · Compounds › Oral incretins · 11 Jan 2025 · 9 likes Post #36 is the version of this I will quote in future. One addition. On variability: the between-person spread in exposure for oral semaglutide is wide enough that two…
-
Fixed versus detachable needles: the trade-offs Replied, post #102 · Devices › Syringes & needles · 9 Jan 2025 · 14 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Books and papers worth reading that are not about this at all Replied, post #15 · Lounge › Off topic · 7 Jan 2025 · 0 likes Practical experience of books and papers, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Started this topic · Compounds › Tirzepatide · 1 Jan 2025 · 58 likes Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — setting out what I have, and where I think it stops being reliable. I have spent a…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #23 · Safety › Adverse events · 20 Dec 2024 · 16 likes Signs of dehydration after repeated vomiting are the most common serious secondary problem described here and are also the most preventable.
-
[2026 update] New subcategory: rationale and scope Replied, post #28 · Meta › Announcements · 28 Nov 2024 · 0 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
Why "any advice?" is the least effective ending for a post Replied, post #69 · Start Here › How to Ask · 24 Nov 2024 · 0 likes Answering the question post #67 raises rather than the one it answers. If you are asking about a document, quote the exact wording of the line you are asking about.…
-
Sample size intuition for a personal experiment Replied, post #2 · Research Methods › Statistics · 8 Nov 2024 · 2 likes Effect size with an interval is more informative than a significance verdict in essentially every case discussed here.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #18 · Sourcing › Regulatory · 29 Oct 2024 · 19 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported.
-
Irish differences from the UK position Replied, post #33 · Regional › UK & Ireland · 12 Oct 2024 · 0 likes Irish differences is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #3 · Access › Shortages · 8 Oct 2024 · 14 likes This settles it for me, at least until somebody posts a reason it should not.
-
Progressive overload when the scale is falling — one year on Replied, post #74 · Nutrition & Training › Resistance training · 20 Sep 2024 · 7 likes Where I part company with post #71, and it is a narrow parting. Two claims get bundled together under Progressive overload and they need separating. The descriptive one…
-
Circumference measurements as a poor man's composition estimate Replied, post #106 · Outcomes › Body composition · 28 Aug 2024 · 16 likes Confirming post #105 from a second method, which matters more than confirming it from a second person. Report the method with the number, always. A composition figure…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #36 · Analytics › COA interpretation · 25 Aug 2024 · 20 likes Where I part company with post #34, and it is a narrow parting. Taking field-by-field walk through a certificate seriously for a moment rather than deflecting: the…
-
Guidelines revision: what changed and why Replied, post #5 · Meta › Announcements · 24 Jul 2024 · 18 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct.
-
Cold packs, phase-change material, and what survives ten days Replied, post #17 · Sourcing › Logistics · 15 Jun 2024 · 1 like Building on post #16 rather than restating it. Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.